Credo Brands Marketing Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 28 May 2026 | Retailing | Market Cap: ₹533 Cr
FY27 growth is expected to be mid-single-digit at the same-store level, with store count largely flat (closing ~20 underperforming stores and opening ~20 new premium stores). FY27 is expected to deliver mid-single-digit same-store sales growth amid inflationary pressures and geopolitical uncertainties, with a largely flat store count due to closures of underperforming stores and opening of premium stores.
From Credo Brands Marketing Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹76.8
Market Cap
₹533 Cr
P/E Ratio
11.0
Revenue Rank
Margin Rank
How does Credo Brands Marketing Ltd rank in Retailing?
Compare Credo Brands Marketing Ltd against every Retailing company this quarter on revenue, margins and earnings-call signals.
Credo Brands Marketing Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹162 Cr, net profit ₹15 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 4- →FY27 growth is expected to be mid-single-digit at the same-store level, with store count largely flat (closing ~20 underperforming stores and opening ~20 new premium stores).
- →Focus on improving throughput per store, store experience, and brand premiumization to drive growth.
- →Long-term strategy targets building a stronger, more aspirational, and sustainable brand over 3-5 years, not rapid short-term growth.
- →Revenue growth will come from increasing revenue per square foot and enhancing online and omnichannel engagement.
- →Current year growth could be constrained due to inflation and geopolitical uncertainties affecting consumer demand.
- →Advertising spend planned to increase (9-10% of revenue) to boost brand visibility and support medium to long-term growth.
- →Overall, measured and cautious near-term outlook with confidence in strong long-term growth potential.
📈 Profitability & Margins
Rank 3- →FY27 is expected to deliver mid-single-digit same-store sales growth amid inflationary pressures and geopolitical uncertainties, with a largely flat store count due to closures of underperforming stores and opening of premium stores.
- →Earnings growth in FY27 may face short-term pressure due to increased advertising spend (9%-10% of revenues) and investments in premiumization and brand building.
- →Gross margin is expected to remain stable within the 56%-58% range, primarily influenced by product mix; however, raw material cost volatility due to global disruptions poses uncertainty.
- →EBITDA margins are anticipated to remain broadly stable, supported by operational efficiencies despite higher marketing expenses.
- →The company’s long-term strategy focuses on sustainable brand strength and premiumization, expecting revenue and profit growth beyond FY27 as brand visibility, conversion, and throughput per store improve over 2-3 years.
- →No specific near-term EPS guidance was given, but stable margins and cautious growth outlook suggest moderate earnings progression in the next 1-2 years.
🏗️ Capital Expenditure Plans
Yes- →Capex per new MUFTI 2.0 format store is around INR 40 lakhs to INR 45 lakhs depending on location (Page 12).
- →For FY27, the company plans to open about 20 new premium format stores and close roughly 20 underperforming stores, keeping store count largely flat (Pages 13 and 11).
- →Capital investments in stores are planned considering lease periods to optimize amortization; renovations and new store openings are part of a gradual process aligned with lease expiries (Pages 8 and 7).
- →The company is investing in scaling the Mufti 2.0 premiumization initiative including enhanced product quality, consumer experience, and better retail environments (Pages 6 and 13).
- →Advertising and branding investments are expected to increase to approximately 8%-10% of revenues to strengthen long-term brand relevance (Pages 4 and 13).
💰 Fundraising & Capital Structure
No information📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
What Credo Brands's management said in earlier quarters
Others in Retailing this season
- Spencer's Retail (Q4 FY26)
Spencer's Retail delivered 8% growth in Q4 FY'26, powered by both online (50% of growth) and offline channels. Key concall takeaways from Spencer's Retail's Q4…
- Urban Company Ltd (Q4 FY26)
InstaHelp is a significant investment area; management commits to consolidated break-even by Q3 FY28 and adjusted EBITDA of INR 1,000 crores by FY31. Key…
- V-Mart Retail (Q4 FY26)
V-Mart is confident of continuing strong same-store sales growth (SSSG) of around 5-10% driven by disciplined expansion and operational efficiencies. Key…
- Vedant Fashions Ltd (Q4 FY26)
. Key concall takeaways from Vedant Fashions Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Credo Brands Marketing Ltd Q4 FY26 results?
FY27 growth is expected to be mid-single-digit at the same-store level, with store count largely flat (closing ~20 underperforming stores and opening ~20 new premium stores). FY27 is expected to deliver mid-single-digit same-store sales growth amid inflationary pressures and geopolitical uncertainties, with a largely flat store count due to closures of underperforming stores and opening of premium stores.
What is Credo Brands Marketing Ltd share price analysis?
Credo Brands Marketing Ltd currently shows a neutral. The stock trades at a P/E of 11.0 with a market cap of ₹533 Cr. Investors should review the full earnings analysis for detailed insights.
Is Credo Brands Marketing Ltd planning capital expenditure?
Capex per new MUFTI 2.0 format store is around INR 40 lakhs to INR 45 lakhs depending on location (Page 12).
Keep Credo Brands Marketing Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.